ELDN Eledon Pharmaceuticals, Inc. - Common Stock
$3,68
Fiyat · May 20, 2026
Temel veriler itibarıyla May 13, 2026
52 Haftlık Aralık
$1–$5
72% of range
Analist Derecelendirmesi
BUY
13 analysts
Fiyat Hedefi
$8
+123% upside
P/E (TTM)
-2.9
ROE
-69.4%
Net Kâr Marjı
—
ELDN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$3.68
Piyasa Değeri
$114M
P/E (TTM)
-2.9
EPS (TTM)
$-0.52
Gelir (TTM)
—
Temettü Verimi
—
ROE
-69.4%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $5
ELDN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
2016-12-31
→
2016-12-31
Hisse Başına Kâr
$-0.52
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ELDN
Akran Ortalaması
P/E (TTM)
-2.9
9.4
P/B (F/D)
1.4
1.8
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ELDN
Akran Ortalaması
ROA
-26.3%
-30.4%
ROE
-69.4%
-54.4%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ELDN
Akran Ortalaması
Current Ratio (Cari Oran)
7.4
3.8
Quick Ratio (Cari Oran)
7.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ELDN
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ELDN
Akran Ortalaması
ELDN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
13 analist
- Güçlü Al 4 30,8%
- Al 8 61,5%
- Tut 1 7,7%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
5 analist · 2026-05-20
Medyan
$8.00
← Tüm hedeflerin altında
$3.68
Düşük
$5.00
Yüksek
$12.00
Medyan hedef
$8.00
+117,4%
Ortalama hedef
$8.20
+122,8%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.22%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.33 | $-0.19 | -0.14% |
| 31 Aralık 2025 | $-0.10 | $-0.21 | 0.11% |
| 30 Eylül 2025 | $-0.21 | $-0.26 | 0.04% |
| 30 Haziran 2025 | $-0.13 | $-0.23 | 0.10% |
| 31 Mart 2025 | $-0.08 | $-0.31 | 0.23% |
| 31 Aralık 2024 | $0.67 | $-0.32 | 0.99% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| DMAC | $428M | — | — | — | -78.7% | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| SABS | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $66M | $52M | $30M | $27M | $24M | $6M | $8M | $7M | $2M | $3M | $33M | $15M | |
| SG&A Expense | $17M | $19M | $13M | $13M | $13M | $10M | $6M | $7M | $11M | $2M | $13M | $9M | |
| Operating Expenses | $83M | $71M | $43M | $88M | $37M | $18M | $16M | $14M | $13M | $5M | $45M | $23M | |
| Operating Income | · | · | $-43M | $-88M | $-37M | $-18M | $-16M | $-14M | $-13M | $-5M | $-45M | $-23M | |
| Other Non-op | $4M | $4M | $3M | $462.0K | $7.0K | $79.0K | $40.0K | $-5.0K | $5.0K | $-527.0K | · | $166.0K | |
| Pretax Income | $-46M | $-36M | $-117M | $-88M | $-37M | $-23M | $-16M | $-14M | $-13M | $-6M | · | · | |
| Income Tax | $35.0K | $431.0K | $0 | $0 | $-2M | $-404.0K | · | · | · | $0 | $0 | $0 | |
| Net Income | $-46M | $-36M | $-117M | $-88M | $-35M | $-23M | $-16M | $-14M | $-13M | $-6M | $-45M | $-23M | |
| EPS (Basic) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | · | · | · | · | · | · | · | |
| Shares (Basic) | 81,836,246 | 48,543,787 | 24,619,197 | 14,285,254 | 14,819,582 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 81,836,246 | 48,543,787 | 24,619,197 | 14,285,254 | 14,819,582 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | $-88M | $-37M | $-18M | $-16M | · | $-13M | · | $-45M | $-23M |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $21M | $5M | $56M | $85M | $114M | $9M | $13M | $17M | $1M | $24M | $105M | |
| Short-term Investments | $111M | $120M | $46M | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $4M | $5M | $3M | $4M | $1M | $1M | $1M | $2M | $33.0K | $3M | $2M | |
| Other Current Assets | $11.0K | $104.0K | $90.0K | $28.0K | $34.0K | $38.0K | $54.0K | $36.0K | $18.0K | $33.0K | · | · | |
| Current Assets | $136M | $144M | $56M | $60M | $88M | $116M | $10M | $14M | $19M | $1M | $67M | $108M | |
| PP&E (Net) | · | · | · | · | · | · | $5.0K | $14.0K | $25.0K | $31.0K | $489.0K | $33.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $228.0K | $654.0K | $91.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | $130.0K | $165.0K | $58.0K | |
| Goodwill | · | · | $0 | $0 | $49M | $49M | · | $2M | $2M | · | · | · | |
| Other Non-current Assets | $322.0K | $363.0K | $186.0K | $150.0K | $400.0K | $383.0K | $639.0K | $869.0K | · | $15.0K | $45.0K | · | |
| Total Assets | $169M | $177M | $89M | $93M | $171M | $197M | $11M | $17M | $21M | $1M | $68M | $108M | |
| Accounts Payable | $4M | $6M | $967.0K | $2M | $2M | $1M | $329.0K | $689.0K | $418.0K | $338.0K | $1M | $765.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $113.0K | $5M | $3M | |
| Current Liabilities | $18M | $12M | $4M | $6M | $4M | $2M | $1M | $3M | · | $4M | $6M | $4M | |
| Capital Leases | $283.0K | $640.0K | $0 | $383.0K | $400.0K | · | $144.0K | · | · | · | · | · | |
| Deferred Tax | $2M | $2M | $2M | $2M | $2M | $4M | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $88.0K | · | |
| Total Liabilities | $32M | $59M | $82M | $9M | $7M | $7M | $1M | $3M | $1M | $4M | $6M | $4M | |
| Common Stock | $75.0K | $60.0K | $24.0K | $14.0K | $14.0K | $15.0K | $1.0K | $9.0K | $7.0K | $1.0K | $23.0K | $22.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $190M | |
| Retained Earnings | $-401M | $-356M | $-319M | $-203M | $-115M | $-80M | $-58M | $-42M | $-28M | $-14M | $-131M | $-86M | |
| AOCI | $24.0K | $26.0K | · | · | · | · | · | · | · | $-1.0K | $-55.0K | · | |
| Stockholders' Equity | $81M | $62M | $-48M | $24M | $164M | $191M | $9M | $14M | $19M | $-3M | $3M | $104M | |
| Liabilities + Equity | $169M | $177M | $89M | $93M | $171M | $197M | $11M | $17M | $21M | $1M | $68M | $108M | |
| Shares Outstanding | 75,430,033 | 59,789,275 | 24,213,130 | 13,776,788 | 14,306,788 | 15,160,397 | 720,408 | 9,422,143 | 7,110,414 | 394,306 | 22,597,144 | 22,382,340 |
Nakit Akışı 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $5.0K | $9.0K | $11.0K | $22.0K | $35.0K | · | · | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Deferred Tax | $5.0K | $431.0K | · | · | $-2M | $-404.0K | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | $2M | $2M | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-47M | $-40M | $-28M | $-29M | $-15M | $-14M | $-12M | $-15M | $-5M | $-41M | $-21M | |
| CapEx | · | · | · | · | · | · | · | · | · | $9.0K | $565.0K | $25.0K | |
| Investing Cash Flow | $11M | $-70M | $-45M | · | · | $11M | · | · | $23M | · | · | · | |
| Stock Issued | · | · | · | · | · | $9M | $10M | $7M | $5M | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $9M | $10M | · | $5M | · | · | · | |
| Financing Cash Flow | $54M | $134M | $33M | · | $-449.0K | $110M | $10M | $8M | $8M | · | · | · | |
| Net Change in Cash | $2M | $16M | $-52M | $-28M | $-29M | $105M | $-4M | $-4M | $16M | $-2M | $-81M | $74M | |
| Taxes Paid | $28.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | $-42M | $-21M |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -26.3% | · | · | -66.8% | -18.8% | -21.9% | -114.5% | · | -118.8% | · | -51.3% | -33.3% | |
| ROE | -69.4% | · | · | -78.1% | -20.6% | -21.5% | -140.3% | · | -156.6% | · | -54.6% | -96.6% | |
| ROIC | · | · | · | -105.0% | -21.0% | -9.5% | · | · | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | · | · | 9.2 | 20.1 | 46.6 | 7.5 | · | · | · | 10.9 | 25.3 | |
| Quick Ratio | 7.3 | · | · | 8.7 | 19.3 | 46.0 | 6.6 | · | · | · | 3.9 | 24.8 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Değerleme (TTM) 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-46M | $-36M | $-117M | $-88M | $-35M | $-23M | $-16M | $-14M | $-13M | $-6M | $-45M | $-23M | |
| Market Cap | $114M | · | · | $31M | $63M | $233M | $135M | · | $520M | · | $31.92B | $53.45B | |
| P/E | -2.9 | -6.2 | -0.4 | -0.4 | -1.9 | · | · | · | · | · | · | · | |
| P/B | 1.4 | · | · | 0.4 | 0.4 | 1.2 | 14.3 | · | 26.7 | · | 517.2 | 516.4 | |
| P / Tangible Book | 1.4 | 3.9 | · | 1.3 | 0.5 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | · | · | -1.1 | -2.2 | -15.3 | -9.8 | · | -34.8 | · | -774.1 | -2530.5 | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | -763.7 | -2527.5 | |
| Earnings Yield | -34.4% | -16.0% | -262.8% | -270.2% | -52.8% | · | · | · | · | · | · | · |
Gelir Tablosu 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $17M | $17M | $15M | $20M | $14M | $18M | $17M | $10M | $7M | $7M | $8M | $7M | $8M | $7M | $7M | $6M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $4M | $7M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | |
| Operating Expenses | $21M | $21M | $19M | $25M | $18M | $25M | $21M | $15M | $11M | $10M | $11M | $10M | $11M | $59M | $11M | $9M | |
| Operating Income | $-21M | · | $-19M | $-25M | $-18M | · | $-21M | $-15M | $-11M | · | $-11M | $-10M | $-11M | · | $-11M | $-9M | |
| Other Non-op | $1M | $540.0K | $1M | $1M | $1M | $1M | $1M | $869.0K | $574.0K | $712.0K | $849.0K | $775.0K | $338.0K | $304.0K | $127.0K | $36.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $-58M | $-10M | $-9M | |
| Net Income | $-39M | $-10M | $-17M | $-11M | $-6M | $-45M | $77M | $-45M | $-24M | $-30M | $-10M | $-66M | $-11M | $-58M | $-10M | $-9M | |
| EPS (Basic) | $-0.33 | $-0.10 | $-0.21 | $-0.13 | $-0.08 | $-0.14 | $1.05 | $-0.92 | $-0.65 | · | $-0.33 | $-2.74 | $-0.75 | $-4.09 | $-0.73 | $-0.65 | |
| EPS (Diluted) | $-0.33 | $-0.10 | $-0.21 | $-0.13 | $-0.08 | $1.19 | $-0.28 | $-0.92 | $-0.65 | · | $-0.33 | $-2.74 | $-0.75 | $-4.09 | $-0.73 | $-0.65 | |
| Shares (Basic) | 112,424,211 | -149,602,653 | 77,156,068 | 77,156,068 | 77,126,763 | -75,669,944 | 51,945,920 | 42,278,411 | 29,989,400 | · | 29,974,400 | 24,006,549 | 14,285,905 | -28,577,249 | 14,265,905 | 14,265,905 | |
| Shares (Diluted) | 112,424,211 | -149,602,653 | 77,156,068 | 77,156,068 | 77,126,763 | -79,202,366 | 55,478,342 | 42,278,411 | 29,989,400 | · | 29,974,400 | 24,006,549 | 14,285,905 | -28,577,249 | 14,265,905 | 14,265,905 | |
| EBITDA | $-21M | · | $-19M | $-25M | $-18M | · | $-21M | $-15M | $-11M | · | $-11M | $-10M | $-11M | · | $-11M | $-9M |
Bilanço 19
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $23M | $4M | $6M | $8M | $21M | $7M | $26M | $6M | $5M | $4M | $41M | $46M | $56M | $66M | $70M | |
| Short-term Investments | $105M | $111M | $90M | $102M | $116M | $120M | $71M | $58M | $37M | $46M | $56M | $30M | · | $0 | · | · | |
| Prepaid Expense | $2M | $2M | $3M | $4M | $3M | $4M | $3M | $4M | $5M | $5M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Other Current Assets | $9.0K | $11.0K | $14.0K | $10.0K | $55.0K | $104.0K | $442.0K | $157.0K | $54.0K | $90.0K | $90.0K | $238.0K | $47.0K | $28.0K | $57.0K | $32.0K | |
| Current Assets | $114M | $136M | $96M | $111M | $128M | $144M | $82M | $87M | $48M | $56M | $63M | $74M | $49M | $60M | $68M | $73M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $49M | $49M | |
| Other Non-current Assets | $177.0K | $322.0K | $476.0K | $346.0K | $354.0K | $363.0K | $210.0K | $255.0K | $185.0K | $186.0K | $233.0K | $224.0K | $369.0K | $150.0K | $155.0K | $303.0K | |
| Total Assets | $147M | $169M | $130M | $145M | $161M | $177M | $115M | $120M | $81M | $89M | $96M | $107M | $82M | $93M | $150M | $155M | |
| Accounts Payable | $7M | $4M | $5M | $6M | $3M | $6M | $6M | $2M | $2M | $967.0K | $465.0K | $2M | $3M | $2M | $4M | $1M | |
| Current Liabilities | $13M | $18M | $14M | $14M | $9M | $12M | $12M | $6M | $4M | $4M | $3M | $5M | $5M | $6M | $6M | $3M | |
| Capital Leases | $186.0K | $283.0K | $376.0K | $467.0K | $555.0K | $640.0K | $315.0K | $386.0K | $0 | · | $83.0K | $184.0K | $284.0K | $383.0K | $461.0K | $299.0K | |
| Deferred Tax | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $46M | $32M | $39M | $39M | $47M | $59M | $39M | $129M | $96M | $82M | $5M | $7M | $8M | $9M | $8M | $5M | |
| Common Stock | $76.0K | $75.0K | $60.0K | $60.0K | $60.0K | $60.0K | $41.0K | $39.0K | $25.0K | $24.0K | $24.0K | $23.0K | $14.0K | $14.0K | $14.0K | $14.0K | |
| Retained Earnings | $-440M | $-401M | $-391M | $-373M | $-362M | $-356M | $-311M | $-388M | $-343M | $-319M | $-234M | $-223M | $-214M | $-203M | $-144M | $-134M | |
| AOCI | $-72.0K | $24.0K | $9.0K | $-48.0K | $-18.0K | $26.0K | $102.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $45M | $81M | $35M | $50M | $59M | $62M | $76M | $-9M | $-15M | $-48M | $91M | $100M | $75M | $84M | $141M | $149M | |
| Liabilities + Equity | $147M | $169M | $130M | $145M | $161M | $177M | $115M | $120M | $81M | $89M | $96M | $107M | $82M | $93M | $150M | $155M | |
| Shares Outstanding | 75,851,722 | 75,430,033 | 59,881,775 | 59,881,775 | 59,881,775 | 59,789,275 | 41,183,102 | 38,506,614 | 24,813,130 | 24,213,130 | 23,545,130 | 23,043,933 | 13,776,788 | 13,776,788 | 13,756,788 | 13,756,788 |
Nakit Akışı 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-23M | $-14M | $-14M | $-18M | $-16M | $-19M | $-12M | $-8M | $-9M | $-9M | $-12M | $-8M | $-10M | $-9M | $-5M | $-6M | |
| Investing Cash Flow | $6M | $-20M | $12M | $15M | $4M | $-47M | $-13M | $-20M | $10M | $10M | $-25M | · | · | · | · | · | |
| Financing Cash Flow | · | $54M | $0 | $0 | $115.0K | $80M | $5M | $48M | $1.0K | $0 | $0 | · | · | · | · | · | |
| Net Change in Cash | $-17M | $19M | $-2M | $-3M | $-12M | $14M | $-19M | $20M | $1M | $945.0K | $-37M | $-6M | $-10M | $-9M | $-5M | $-6M |
Kârlılık 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -25.3% | · | -14.3% | -8.5% | · | · | 73.1% | -39.5% | · | · | -8.4% | -7.3% | -8.8% | · | -6.4% | -5.5% | |
| ROE | -75.3% | · | -31.3% | -53.6% | · | · | 92.0% | -98.2% | · | · | -8.9% | -7.7% | -9.3% | · | -6.7% | -5.6% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | · | 6.7 | 8.1 | 13.9 | · | 6.5 | 14.5 | 11.3 | · | 21.7 | 15.0 | 8.9 | · | 10.8 | 22.2 | |
| Quick Ratio | 8.3 | · | 6.5 | 7.8 | 13.6 | · | 6.3 | 13.9 | 10.1 | · | 20.6 | 14.6 | 8.5 | · | 10.5 | 21.5 |
Değerleme (TTM) 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | |
| Net Income TTM | $-74M | · | $42M | $14M | $2M | · | $-1M | $-144M | $-110M | · | $-97M | $-96M | $-40M | · | $-39M | $-36M | |
| Market Cap | $234M | · | $155M | $162M | $203M | · | $103M | $102M | $51M | · | $32M | $32M | $33M | · | $38M | $34M | |
| P/E | -4.1 | · | -3.7 | -1.9 | -1.8 | · | -1.1 | -0.6 | -0.5 | · | -0.3 | -0.3 | -0.8 | · | -1.0 | -1.0 | |
| P/B | 5.2 | · | 4.4 | 3.2 | 3.4 | · | 1.3 | -12.0 | -3.5 | · | 0.4 | 0.3 | 0.4 | · | 0.3 | 0.2 | |
| P / Tangible Book | 5.2 | · | 4.4 | 3.2 | 3.4 | · | 1.3 | · | · | · | 0.4 | 0.3 | 0.4 | · | 0.4 | 0.3 | |
| P / Cash Flow | -10.3 | · | · | · | -12.6 | · | · | · | -5.8 | · | · | · | -3.3 | · | · | · | |
| Earnings Yield | -24.3% | · | -27.0% | -52.0% | -56.9% | · | -87.5% | -175.8% | -217.0% | · | -332.1% | -355.5% | -119.5% | · | -98.9% | -102.5% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-46M | $-36M | $-117M | $-88M | $-35M |
| Seyreltilmiş Hisse Başı Kâr | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 7.4 | — | — | 9.2 | 20.1 |
| Cari Oran | 7.3 | — | — | 8.7 | 19.3 |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.